Clinical Trial Update: Effect of Trastuzumab on Disease Free Survival in Early Stage HER2-Negative Breast Cancer Patients With ERBB2 Expressing Disseminated Tumor Cells [Phase 2]

View source ↗

Summary

Phase 2 trial investigating whether trastuzumab affects disease-free survival in early-stage HER2-negative breast cancer patients with ERBB2-expressing dissemin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Trastuzumab (trastuzumab)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Breast Neoplasms | Phase 2 | Status: TERMINATED | Results posted: 2022-11-01